Publications

Probiotics and Prebiotics: Prospects for Public Health and Nutritional Recommendations

Sanders ME, Lenoir-Wijnkoop I, Salminen S, Merenstein D, Pot B, Petschow BW, Nieuwdorp. M, Tancredi D, Cifelli D, Jacques P, Gibson G. 2014. Probiotics and Prebiotics: Prospects for Public Health and Nutritional Recommendations. Annals NY Acad Sci 1309:19-29.

Can prebiotics and probiotics improve therapeutic outcomes for undernourished individuals?

Sheridan PO, Bindels L, Saulnier DM, Reid G, Nova E, Holmgren K, O’Toole PW, Bunn J, Delzenne N, Scott KP. 2013. Can prebiotics and probiotics improve therapeutic outcomes for undernourished individuals? Gut Microbes 5(1):1-9.

Prebiotic mechanisms, functions and applications – A review

Blatchford P, Ansell J, Godoy, MRC, Fahey G, Garcia-Mazcorro JF, Gibson GR, Goh. YJ, Hotchkiss AT, Hutkins R, LaCroix C, Rastall RA, Reimer R, Schoterman M, Van. Sinderen D, Venema K, Whelan K. 2013. Prebiotic mechanisms, functions and applications – A review. Int J Probiotics Prebiotics 8:109-132.

Probiotics, prebiotics, and the host microbiome: the science of translation

Petschow B. Doré J, Hibberd P, Dinan T, Reid G, Blaser M, Cani P, Degnan, F, Foster J, Gibson G, Hutton J, Klaenhammer TR, Ley R, Nieuwdorp M, Pot B, Relman. D, Serazin A and Sanders ME. 2013. Probiotics, prebiotics, and the host microbiome: the science of translation. Annals of the New York Academy of Sciences 1306:1-17.

Improved neonatal outcomes with probiotics

Shane AL, Deshpande GC, Merenstein D. Improved neonatal outcomes with probiotics. JAMA Pediatr. 2013; 167:885-6.

The Intestinal Microbiome, Probiotics, and Prebiotics in Neurogastroenterology

Saulnier DM, Ringel Y, Heyman MB, Foster JA, Bercik P, Shulman RJ, Versalovic J, Verdu E, Dinan TG, Hecht G, Guarner F. 2013. The Intestinal Microbiome, Probiotics, and Prebiotics in Neurogastroenterology. Gut Microbes 4:17-27.

Clinical studies involving probiotics. When FDA’s investigational new drug rubric applies—and when it may not

Degnan, F. 2012. Clinical studies involving probiotics. When FDA’s investigational new drug rubric applies—and when it may not. Gut Microbes 3:485-489. And related letter to the editor.

Virulence or niche factors; what’s in a name?

Hill, C. Virulence or niche factors; what’s in a name? 2012. J Bacteriol. 194(21):5725-7.

Exploring a Road Map to Counter Misconceptions About the Cervicovaginal Microbiome and Disease

Macklaim JM, Cohen CR, Donders G, Gloor GB, Hill JE, Parham GP, Ravel J, Spear G, van de Wijgert J, Reid G. Exploring a Road Map to Counter Misconceptions About the Cervicovaginal Microbiome and Disease. Reprod Sci. 2012; 19:1154-62

Probiotics and prebiotics to combat enteric diarrheal diseases and HIV in the developing world: a consensus report

Monachese M, Cunningham-Rundles S, Diaz MA, Ermond E, Guerrant R, Hummelen R, Kemperman R, Kerac M, Kort R, Merenstein D, Panigrahi P, Ramakrishna B, Safdar N, Shane A, Trois L, Reid G. 2011. Probiotics and prebiotics to combat enteric diarrheal diseases and HIV in the developing world: a consensus report. Gut Microbes 2:198-207.

 Recommendations for the viability assessment of probiotics as concentrated cultures and in food matrices

Champagne CP, Ross RP, Saarela M, Hansen KF, Charalampopoulos D. Recommendations for the viability assessment of probiotics as concentrated cultures and in food matrices. Appl Environ Microbiol. Int J Food Microbiol. 2011 Oct 3;149(3):185-93.

Probiotic and prebiotic claims in Europe: seeking a clear roadmap

Human Gut Microbiota and Their Relationship to Health and Disease

Wallace TC, Guarner F, Madsen K, Cabana M, Gibson G, Hentges E, Sanders ME. 2011. Human Gut Microbiota and Their Relationship to Health and Disease. Nutrition Reviews 69:392-403.

Health claims substantiation for probiotic and prebiotic products

Sanders ME, Heimbach JT, Pot B, Tancredi D, Lenoir-Wijnkoop I, Lähteenmäki-Uutela A, Gueimonde M, Bañares S. 2011. Health claims substantiation for probiotic and prebiotic products. Gut Microbes 2:1-7.

Probiotics and prebiotics to combat enteric diarrheal diseases and HIV in the developing world: a consensus report

Monachese M, Cunningham-Rundles S, Diaz MA, Ermond E, Guerrant R, Hummelen R, Kemperman R, Kerac M, Kort R, Merenstein D, Panigrahi P, Ramakrishna B, Safdar N, Shane A, Trois L, Reid G. 2011. Probiotics and prebiotics to combat enteric diarrheal diseases and HIV in the developing world: a consensus report. Gut Microbes 2:198-207.

How can probiotics and prebiotics impact mucosal immunity?

O’Flaherty S, Saulnier D, Pot B, Versalovic J. How can probiotics and prebiotics impact mucosal immunity? Gut Microbes 2010; 1(5): 293-300.

The media and probiotics: provocation or dialogue?

Reid G. 2010. The media and probiotics: provocation or dialogue? International Journal of Probiotics and Prebiotics 5(4):165-168.

International Scientific Association for Probiotics and Prebiotics 2010 Meeting Report

Sanders ME. 2010. International Scientific Association for Probiotics and Prebiotics 2010 Meeting Report. Functional Food Reviews 2:131-140.

Putting science first – The International Scientific Association for Probiotics and Prebiotics (ISAPP)

Reid G. 2010. Putting science first – The International Scientific Association for Probiotics and Prebiotics (ISAPP). Functional Food Reviews. 2:124-130.

Guide to designing, conducting, publishing, and communicating results of clinical studies involving probiotic applications in human participants

Shane AL, Cabana M, Vidry S, Merenstein D, Hummelen R, Ellis CL, Heimbach JT, Hempel S, Lynch S, Sanders ME, Tancredi DJ. 2010. Guide to designing, conducting, publishing, and communicating results of clinical studies involving probiotic applications in human participants. Gut Microbes 1:243-253.

Dietary prebiotics: Current status and new definition

Gibson GR, Scott KP, Rastall RA, Tuohy KM, Hotchkiss A, Dubert-Ferrandon A, Gareau M, Murphy EF, Saulnier D, Loh G, Macfarlane S, Delzenne N, Ringel Y, Kozianowski G, Dickmann R, Lenoir-Wijnkoop I, Walker C, Buddington R. 2010. Dietary prebiotics: Current status and new definition. IFIS Functional Foods Bulletin 7(1):1–19.

Responders and non-responders to probiotic interventions: how can we improve the odds?

Reid G, Gaudier E, Guarner F, Huffnagle GB, Macklaim J, Munoz AM, Martini M, Ringel-Kulka T, Sartor B, Unal R, Verbeke K, Walter J. 2010. Responders and non-responders to probiotic interventions: how can we improve the odds? Gut Microbes 1(3):1-5.

Safety assessment of probiotics for human use

Sanders ME, Akkermans LMA, Haller D, Hammerman C, Heimbach J, Huys G, Levy D, Mack D, Phothirath P, Constable A, Solano-Aguilar G, Vaughan E. 2010. Safety assessment of probiotics for human use. Gut Microbes 1 (3):1-22.

No causal link between obesity and probiotics

Delzenne N, Reid G. No causal link between obesity and probiotics. Nat Rev Microbiol. 2009 Dec;7(12):901

Probiotic prophylaxis in predicted severe acute pancreatitis

Reid G, Gibson G, Sanders ME, Guarner F, Versalovic J. 2008. Probiotic prophylaxis in predicted severe acute pancreatitis. The Lancet 372:112-113.